A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?-Reference-Cited by-同舟云学术

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

Published:2009-12-03 Issue:3 Volume:119 Page:653-661
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Park Yeon Hee,Kim Seung Tae,Cho Eun Yoon,Choi Yoon La,Ok Oh-Nam,Baek Hae Jin,Lee Jeong Eon,Nam Seok Jin,Yang Jung-Hyun,Park Won,Choi Doo Ho,Huh Seung Jae,Ahn Jin Seok,Im Young-Hyuck

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-009-0665-x.pdf

Reference62 articles.

1. Miller BA, Feuer EJ, Hankey BF (1993) Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 43:27–41

2. Jemal A, Clegg LX, Ward E et al (2004) Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101:3–27

3. Schootman M, Jeffe D, Reschke A et al (2004) The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat 85:219–222

4. Rosen PP, Groshen S, Kinne DW et al (1993) Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 11:2090–2100

5. Joensuu H, Pylkkänen L, Toikkanen S (1999) Late mortality from pT1N0M0 breast carcinoma. Cancer 85:2183–2189

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database;Clinical Breast Cancer;2022-12

2. Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study;Breast Cancer Research and Treatment;2022-08-06

3. A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm;Frontiers in Oncology;2022-06-23

4. Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study;Scientific Reports;2022-01-20

5. Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer;Therapeutic Advances in Medical Oncology;2022-01